Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients

MLA

Sulayman Benmerzoug, et al. “Siglec-7 May Limit Natural Killer Cell–mediated Antitumor Responses in Bladder Cancer Patients.” European Urology Open Science, vol. 34, no. 79–82, Dec. 2021, pp. 79–82. EBSCOhost, https://doi.org/10.1016/j.euros.2021.10.001.

APA

Sulayman Benmerzoug, Mathieu F. Chevalier, Laura Villier, Sylvain Nguyen, Valérie Cesson, Anna K. Schneider, Florence Dartiguenave, Sonia-Christina Rodrigues-Dias, Ilaria Lucca, Patrice Jichlinski, Beat Roth, Denise Nardelli-Haefliger, & Laurent Derré. (2021). Siglec-7 May Limit Natural Killer Cell–mediated Antitumor responses in Bladder Cancer Patients. European Urology Open Science, 34(79–82), 79–82. https://doi.org/10.1016/j.euros.2021.10.001

Chicago

Sulayman Benmerzoug, Mathieu F. Chevalier, Laura Villier, Sylvain Nguyen, Valérie Cesson, Anna K. Schneider, Florence Dartiguenave, et al. 2021. “Siglec-7 May Limit Natural Killer Cell–mediated Antitumor Responses in Bladder Cancer Patients.” European Urology Open Science 34 (79–82): 79–82. doi:10.1016/j.euros.2021.10.001.